Genetic Technologies (NASDAQ:GENE) Share Price Passes Above 200-Day Moving Average of $0.92
Genetic Technologies Limited (NASDAQ:GENE)’s share price passed above its 200-day moving average during trading on Wednesday . The stock has a 200-day moving average of $0.92 and traded as high as $1.96. Genetic Technologies shares last traded at $1.96, with a volume of 200 shares.
Separately, ValuEngine upgraded shares of Genetic Technologies from a “hold” rating to a “buy” rating in a research report on Wednesday, September 4th.
The company has a 50-day moving average of $1.36 and a 200 day moving average of $0.92.
About Genetic Technologies (NASDAQ:GENE)
Genetic Technologies Limited, a molecular diagnostics company, provides predictive testing and assessment tools to help physicians manage the women's health in Australia and the United States. The company's lead product is the BREVAGenplus, a clinically validated risk assessment test for non-hereditary breast cancer.
Featured Story: How to interpret the current ratio
Receive News & Ratings for Genetic Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Genetic Technologies and related companies with MarketBeat.com's FREE daily email newsletter.